BIOA — Bioiasis AD Income Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.001 | 0 | 0 | 0 | 0.012 |
Cost of Revenue | |||||
Gross Profit | -0.033 | -0.039 | -0.029 | -0.033 | -0.042 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.061 | 0.075 | 0.075 | 0.079 | 0.095 |
Operating Profit | -0.06 | -0.075 | -0.075 | -0.079 | -0.083 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.607 | -0.066 | -0.08 | 0.013 | -0.479 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.535 | -0.05 | -0.078 | 0.005 | -0.479 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.535 | -0.05 | -0.078 | 0.005 | -0.479 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.535 | -0.05 | -0.078 | 0.005 | -0.479 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.457 | -0.04 | -0.064 | 0.006 | -0.409 |